Reappraisal of the 3,5,3'-triiodothyronine-suppression test in the prediction of long term outcome of antithyroid drug therapy in patients with hyperthyroid Graves' disease.

Source:http://linkedlifedata.com/resource/pubmed/id/6421866

Download in:

View as

General Info

PMID
6421866